Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5731296 | ASTELLAS | Selective vasodilation by continuous adenosine infusion |
Mar, 2015
(9 years ago) |
Market Authorisation Date: 18 May, 1995
Treatment: Selective vasodilation by continuous adenosine infusion
Dosage: SOLUTION;INTRAVENOUS